1. Blauvelt A. Pityriasis rosea.

In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS,

Leffell DJ, Wolff K, editors. Dermatology in general medicine fitzpatrick’s. 8th
ed. New York: The McGraw-Hill Companies; 2012. p. 458-63.
2. James WD, Berger TG, Elston DM, Neuhaus IM. Andrews’ diseases of the skin
clinical dermatology. 12th ed. Philadelphia: Elsevier; 2016. p. 199-201
3. Sterling JC. Viral infection. In: Griffiths CEM, Barker J, Bleiker T, Chalmers R,
Creamer D, editors. Rook’s textbook of dermatology. 8th ed. Massachusetts:
Blackwell publishing; 2016. p. 33.78-81.
4. Nikolic M. Pityriasis Rosea. In: European Handbook of Dermatological
Treatments. 3rd ed. Berlin: Springer-Verlag Berlin Heidelberg; 2015. p. 749-52
5. Drago F, Ciccarese G, Rebora A, Broccolo F, Parodi A. Pityriasis rosea: a
comprehensive classification. Dermatology. 2016;232(4):431-7
(https://www.karger.com/Article/Abstract/445375 diakses pada 19 Juni 2018).
6. Konsil Kedokteran Indonesia. Standar kompetensi dokter indonesia. Jakarta:
KKI; 2012. hal. 54.
7. Drago F, Ciccarese G, Broccolo F, Ghio M, Contini P, Thanasi H. The Role of
Cytokines, Hemokines, and Growth Factors in the Pathogenesis of Pityriasis
Rosea. Hindawi Publishing Corporation: Mediators Inflamm. 2015;115(10):1-6
(https://www.hindawi.com/journals/mi/2015/438963/abs/ diakses pada 22 Juni
2018).
8. GanGuly S. A Randomized, Double-Blind, Placebo-Controlled Study of Efficacy
of Oral Acyclovir in the Treatment of Pityriasis rosea. Journal of clinical and
diagnostic research: JCDR. 2014 May;8(5):YC01
(https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080052/ diakses pada 22 Juni
2018).
9. Weller, R.B. Hamish JA, Hunter, Margaret WM. Clinical Dermatology. 5th ed.
John Wiley & Sons, Ltd; 2015. p.68-69.
10. Kartowigno S. Pitiriasis rosea. In: Sepuluh besar kelompok penyakit kulit.
Palembang: Unsri Press; 2012. p. 93-5.
11. Broccolo F, Drago F, Careddu AM, et al. Additional evidence that pityriasis rosea
is associated with reactivation of human herpesvirus-6 and -7. J Invest Dermatol.
2005; 124:1234-40.
12. Chuh, A et al. 2004. Pityriasis Rosea – evidence for and against at infectious
disease. Cambridge University Press: Cambridge Journal 132:3:381-390.

10. Neoh, C. Y., et al. "Characterization of the inflammatory cell infiltrate in herald
patches and fully developed eruptions of pityriasis rosea." Clinical and experimental
dermatology 35.3 (2010): 300-304.
13. Djuanda A, Triestianawati W. Pitiriasis rosea. In: Menaldi SL, editor. Ilmu
penyakit kulit dan kelamin. 7th ed. Jakarta: Fakultas Kedokteran Universitas
Indonesia; 2015. p. 225-7.
14. Wolff, K., Johnson, R.A., Suurmond, D. Fitzpatrick Color Atlas and Synopsis of
Clinical Dermatology Edition 5th.The McGraw-Hill Companies. United States.
2005
15. Zawar V, Chuh A. Applicability of proposed diagnostic criteria of pityriasis
rosea: results of a prospective case-control study in india. Indian J Dermatol.
2013;58(6):439-42.
16. Ganguly, Satyaki. "A randomized, double-blind, placebo-controlled study of
efficacy of oral acyclovir in the treatment of pityriasis rosea." Journal of clinical
and diagnostic research: JCDR 8.5 (2014): YC01.
17. Stulberg, D. L., Jeff W. Pityriasis Rosea. Am Fam
Physician. 2004 Jan 1;69(1):87-91.
18. Amatya, A., E. A. Rajouria, and D. K. Karn. "Comparative study of effectiveness
of oral acyclovir with oral erythromycin in the treatment of pityriasis rosea."
Kathmandu University Medical Journal 10.1 (2012): 48-52.